MoneyWorks4Me

Suven Life Sciences - Quaterly Results

04 Nov 2023 Evaluate
The sales slipped to Rs. 30.60 millions, down -30.23% for the September 2023 quarter as against Rs. 43.86 millions during the year-ago period.The Total Profit for the quarter ended September 2023 of Rs. 27.55 millions grew from Rs.-89.33 millions Operating profit Margin for the quarter ended September 2023 improved to -29.34% as compared to -72.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 30.60 43.86 -30.23 68.57 79.25 -13.48 135.39 118.44 14.31
Other Income 51.42 2.06 2396.12 107.82 6.42 1579.44 84.49 16.01 427.73
PBIDT -29.34 -72.44 -59.50 -40.89 -138.74 -70.53 -192.95 -350.41 -44.94
Interest 0.42 0.69 -39.13 0.93 1.71 -45.61 2.89 5.30 -45.47
PBDT 44.81 -73.13 -161.27 32.75 -80.45 -140.71 -135.84 -318.55 -57.36
Depreciation 17.26 16.20 6.54 33.91 32.01 5.94 65.43 43.93 48.94
PBT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -95.88 -165.16 -41.95 -59.63 -175.07 -65.94 -142.51 -295.85 -51.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..